Bsw Wealth Partners Editas Medicine, Inc. Transaction History

Bsw Wealth Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $170 - $271	-14 Reduced 0.14%	10,291 $126,000
Q2 2022 Aug 15, 2022	BUY	$9.99 - $21.35 $102,946 - $220,011	10,305 New	10,305 $122,000
Q4 2019 Feb 18, 2020	SELL	$19.49 - $32.63 $22,413 - $37,524	-1,150 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$22.49 - $26.81 $854 - $1,018	38 Added 3.42%	1,150 $26,000
Q2 2019 Aug 13, 2019	BUY	$20.48 - $27.76 $22,773 - $30,869	1,112 New	1,112 $28,000

250

57.1M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $92.1M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Bsw Wealth Partners with notifications on news.